On November 12, 2025, AEON Biopharma, Inc. entered into a Securities Purchase Agreement to raise funds through a private placement of shares and warrants, with expected sales of approximately 1.96 million shares at $0.9116 each, and an additional 4.6 million shares contingent on stockholder approval. This is a significant event for the company.